Clinical Trial Update: Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of metformin as chemoprevention in non-small cell lung cancer was terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Mayo Clinic | Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: TERMINATED | Results posted: 2019-06-19